Is there any clinical reason to administer anticoagulant therapy to patients with the Jugular Vein Nutcracker syndrome?
Submitted: 14 November 2023
Accepted: 17 November 2023
Published: 23 November 2023
Accepted: 17 November 2023
Abstract Views: 483
PDF: 55
HTML: 0
HTML: 0
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Chiara Angelini, Giorgio Mantovani, Michele Alessandro Cavallo, Alba Scerrati, Pasquale De Bonis, Neurosurgical implications of the Jugular Vein Nutcracker , Veins and Lymphatics: Vol. 12 (2023)
- Ilaria Massi, Paolo Zamboni, What are the ideal characteristics of a venous stent? , Veins and Lymphatics: Vol. 10 (2021)
You may also start an advanced similarity search for this article.